JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Germing", 
        "givenName": "Ulrich", 
        "id": "sg:person.01362464041.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital St Louis (Assistance Publique \u2013H\u00f4pitaux de Paris) and Paris 7 University, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "H\u00f4pital St Louis (Assistance Publique \u2013H\u00f4pitaux de Paris) and Paris 7 University, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fenaux", 
        "givenName": "Pierre", 
        "id": "sg:person.0766554473.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766554473.71"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2018-06-06", 
    "datePublishedReg": "2018-06-06", 
    "description": "In 1993 Silverman and coworkers [1] reported on a phase 2 trial on 43 patients with higher-risk MDS (medullary blast count >10%) using 75\u00a0mg/m2 5-Azacytidine (5-Aza) for 7\u00a0days every 28\u00a0days for 6 cycles. Forty-nine percent of the patients responded, with 12% CR (CR and PR 37%, and 5% improved hematologically without achieving CR or PR), and 51% were nonresponders. This report was the first to show that 5-Aza can result in remission in a reasonable proportion of the patients, and results were very closely reproduced in phase 2 and 3 trials [2\u201318]. The drug was regarded as differentiating agent, and the authors speculated if 5-Aza was the first drug with benefit for older MDS patients. In 1997 Wijermans et al. [19] published promising phase 2 data on decitabine in high-risk MDS with similar results and subsequently worked on different schedules and on cytogenetic responses as well. Having in mind the very poor prognosis of older high-risk MDS patients after induction chemotherapy [20, 21], the efficacy of HMA appears to be an attractive alternative.", 
    "editor": [
      {
        "familyName": "Platzbecker", 
        "givenName": "Uwe", 
        "type": "Person"
      }, 
      {
        "familyName": "Fenaux", 
        "givenName": "Pierre", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-76879-3_10", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-76878-6", 
        "978-3-319-76879-3"
      ], 
      "name": "Myelodysplastic Syndromes", 
      "type": "Book"
    }, 
    "keywords": [
      "high-risk MDS", 
      "hypomethylating agent", 
      "MDS patients", 
      "promising phase 2 data", 
      "high-risk MDS patients", 
      "older MDS patients", 
      "phase 2 trial", 
      "phase 2 data", 
      "induction chemotherapy", 
      "cytogenetic response", 
      "poor prognosis", 
      "first drug", 
      "patients", 
      "different schedules", 
      "phase 2", 
      "trials", 
      "drugs", 
      "days", 
      "remission", 
      "similar results", 
      "nonresponders", 
      "chemotherapy", 
      "prognosis", 
      "agents", 
      "decitabine", 
      "efficacy", 
      "treatment", 
      "MD", 
      "report", 
      "percent", 
      "reasonable proportion", 
      "proportion", 
      "response", 
      "attractive alternative", 
      "schedule", 
      "benefits", 
      "m2", 
      "results", 
      "data", 
      "alternative", 
      "authors", 
      "cycle", 
      "coworkers", 
      "et al", 
      "mind", 
      "Cr", 
      "Silverman", 
      "al"
    ], 
    "name": "Treatment with Hypomethylating Agents (HMA)", 
    "pagination": "131-139", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104407947"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-76879-3_10"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-76879-3_10", 
      "https://app.dimensions.ai/details/publication/pub.1104407947"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-08-04T17:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/chapter/chapter_238.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-76879-3_10"
  }
]

Download the RDF metadata as:  json-ld nt turtle xml License info

This table displays all metadata directly associated to this object as RDF triples.

122 TRIPLES      22 PREDICATES      72 URIs      65 LITERALS      7 BLANK NODES